Pages that link to "Q35754181"

The following pages link to Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression (Q35754181):

Displaying 45 items.

• Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies (Q26765342) (← links)
• Role of histone deacetylases in pancreas: Implications for pathogenesis and therapy (Q26774080) (← links)
• Human correlates of provocative questions in pancreatic pathology (Q27023576) (← links)
• SIBLINGs and SPARC families: their emerging roles in pancreatic cancer (Q27027759) (← links)
• FGF receptors: cancer biology and therapeutics (Q28291186) (← links)
• Joint network and node selection for pathway-based genomic data analysis (Q30643757) (← links)
• Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents (Q33704284) (← links)
• CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways (Q33721133) (← links)
• Pancreatic ductal adenocarcinoma: long-term survival does not equal cure (Q34639984) (← links)
• Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells (Q34645532) (← links)
• Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling (Q34708273) (← links)
• Novel regulatory program for norepinephrine-induced epithelial-mesenchymal transition in gastric adenocarcinoma cell lines (Q35051882) (← links)
• S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line (Q35583899) (← links)
• Rare long-term survivors of pancreatic adenocarcinoma without curative resection (Q36401628) (← links)
• Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase (Q36446801) (← links)
• The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis (Q37179521) (← links)
• Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy (Q37321961) (← links)
• Cancer stem cells, tumor dormancy, and metastasis (Q38056500) (← links)
• Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer (Q38073775) (← links)
• Role of epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma: is tumor budding the missing link? (Q38142155) (← links)
• SMAD4 and its role in pancreatic cancer (Q38281261) (← links)
• Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer (Q38514906) (← links)
• The role of TGF-β and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma (Q38788923) (← links)
• GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1. (Q38895410) (← links)
• Snail cooperates with Kras G12D in vivo to increase stem cell factor and enhance mast cell infiltration (Q38983127) (← links)
• The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance. (Q39076794) (← links)
• ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer. (Q40961838) (← links)
• Snail cooperates with KrasG12D to promote pancreatic fibrosis (Q41859988) (← links)
• BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen (Q42128109) (← links)
• Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer (Q42234716) (← links)
• c-Met in pancreatic cancer stem cells: therapeutic implications. (Q42426376) (← links)
• Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasia (Q42457687) (← links)
• Immunohistochemical analysis of E-cadherin and zeste homolog 2 expression in endoscopic ultrasound-guided fine-needle aspiration of pancreatic adenocarcinoma (Q45205085) (← links)
• Galectin-3 and Cancer Stemness. (Q47190193) (← links)
• 212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models (Q50138482) (← links)
• Analysis of the origin of anaplastic pancreatic cancer and the mechanism of its dedifferentiation (Q51209052) (← links)
• Smad4 and epithelial-mesenchymal transition proteins in colorectal carcinoma: an immunohistochemical study. (Q52375024) (← links)
• The role of miR-21 and miR-211 on MMP9 regulation in pancreatic ductal adenocarcinoma: cooperation in invasiveness behaviors? (Q53467383) (← links)
• Akt-mediated transforming growth factor-β1-induced epithelial-mesenchymal transition in cultured human esophageal squamous cancer cells. (Q54349158) (← links)
• Loss of Disabled-2 Expression in Pancreatic Cancer Progression (Q64264838) (← links)
• TGF-β enhances the cytotoxic activity of Vδ2 T cells (Q90468455) (← links)
• Pharmacokinetic evaluation and antitumor potency of liposomal nanoparticle encapsulated cisplatin targeted to CD24-positive cells in ovarian cancer (Q90480539) (← links)
• Quasimesenchymal phenotype predicts systemic metastasis in pancreatic ductal adenocarcinoma (Q91229414) (← links)
• Expression and Role of MicroRNAs from the miR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic Cancer (Q92124218) (← links)
• DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal Cancers (Q92257934) (← links)